Corpus Intelligence IC Memo — PERHAM MEMORIAL HOSPITAL AND HOME 2026-04-26 12:47 UTC
IC Memo — PERHAM MEMORIAL HOSPITAL AND HOME
Investment Committee Memorandum | MN | 25 beds | Grade C | EBITDA uplift $4.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PERHAM MEMORIAL HOSPITAL AND HOME

CCN 241373 | OTTER TAIL, MN | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PERHAM MEMORIAL HOSPITAL AND HOME is a 25-bed suburban community hospital in OTTER TAIL, MN with $65.7M in net patient revenue and a -3.8% operating margin. The hospital serves a payer mix of 34.8% Medicare, 3.3% Medicaid, and 62.0% commercial.

Thesis: Turnaround. Our ML models identify $4.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.8% to 3.5% (+736bps).

Net Revenue HCRIS$65.7M
Current EBITDA COMPUTED$-2.5M
Operating Margin COMPUTED-3.8%
Occupancy HCRIS32.7%
Revenue / Bed COMPUTED$2.6M
Net-to-Gross HCRIS50.2%
Distress Probability ML52.1%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
92
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -3.8% places it below the state median. Among 92 size-comparable peers (12-50 beds), the median margin is -2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PERHAM MEMORIAL HOSPITAL AND H (Target)MN25$65.7M-3.8%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
ST. MARYS REGIONAL HEALTH CENTMN36$167.8M3.1%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
ESSENTIA HEALTH VIRGINIAMN49$132.0M-5.0%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%
LAKEWOOD HEALTH SYSTEMMN25$124.7M0.2%
NORTHFIELD CITY HOSPITALMN37$121.8M-8.4%
GRAND ITASCA CLINIC AND HOSPITMN34$117.7M5.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$800K+122bp9mo
Clean Claim Rate88.0%96.0%$42K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$800K
Clean Claim Rate
$42K
Total EBITDA Uplift$4.8M
Current EBITDA$-2.5M
+ RCM Uplift+$4.8M
Pro Forma EBITDA$2.3M
Current Margin-3.8%
Pro Forma Margin3.5%
WC Released (1x)$2.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.9M$31.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.9M$33.7M0.00x-100.0%
Bull Case9.0x11.0x$-3.5M$48.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.5M$51.8M0.00x-100.0%
Bear Case11.0x10.0x$-4.3M$8.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.3M$8.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 32.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 12-50 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-9.7% / P50=-2.0% / P75=3.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.